PD-(L)1

metastatic melanoma (26 products)

metastatic non-small cell lung cancer (15 products)

Melanoma (15 products)

NSCLC (13 products)

advanced non-squamous NSCLC (13 products)

Metastatic Castration-Resistant Prostate Cancer (11 products)

Stage III melanoma (11 products)

metastatic ocular melanoma (10 products)

Unresectable Melanoma (10 products)

glioblastoma (7 products)

Melanoma and Merkel Cell Carcinoma (7 products)

Pediatric melanoma (7 products)

unresectable/metastatic melanoma (7 products)

metastatic cutaneous melanoma (6 products)

high-risk stage IIIB–IV cutaneous melanoma (6 products)

BRAF V600E Mutation-Positive Unresectable or Metastatic Melanoma (6 products)

stage III/IV resectable melanoma (6 products)

Resectable NSCLC (5 products)

mucosal melanoma (5 products)

unresectable stage IIIA/IIIB NSCLC (5 products)

melanoma brain metastases (5 products)

advanced-stage, anti-PD1/PD-L1 relapsed/refractory solid tumors (4 products)

Unresectable stage III/IV melanoma (4 products)

Metastatic Cancer (4 products)

advanced NSCLC and melanoma (4 products)

stage III/IV unresectable melanoma (4 products)

recurrent or metastatic head and neck squamous cell carcinoma (3 products)

advanced malignancies (3 products)

stage IV metastatic melanoma (3 products)

stage IV NSCLC (3 products)

Advanced NSCLC with EGFR mutation (3 products)

BRAF-mutant melanoma (3 products)

malignant mesothelioma (3 products)

metastatic hormone sensitive prostate cancer (3 products)

melanoma with leptomeningeal disease (3 products)

Resectable stage IIIB/IIIC/IIID or IV melanoma (3 products)

Triple-negative breast cancer (2 products)

urothelial carcinoma (2 products)

non-small lung cancer (2 products)

Platinum-sensitive recurrent ovarian carcinoma (2 products)

Uveal melanoma (2 products)

Lung cancer (2 products)

melanoma or lung cancer with autoimmune disease (2 products)

melanoma or lung cancer without autoimmune disease (2 products)

Unresectable stage III non-small cell lung cancer (2 products)

unresectable stage 3 NSCLC (2 products)

clinical stages IIIB-IIID melanoma (2 products)

Ipilimumab-Naive Melanoma (2 products)

Stage I NSCLC (2 products)

Advanced non-small cell lung cancer with actionable driver oncogenes (2 products)

resectable stage IIIA NSCLC (2 products)

Advanced NSCLC and HNSCC (2 products)

stage IIIA melanoma (2 products)

platinum-resistant/refractory epithelial ovarian cancer (2 products)

dMMR/MSI-H metastatic colorectal cancer (2 products)

Advanced soft tissue sarcoma (2 products)

Stage IIIA NSCLC (2 products)

MMRd recurrent/metastatic endometrial cancer (1 products)

head and neck cancer (1 products)

Advanced solid tumors (ovarian, prostate, breast cancer) (1 products)

recurrent endometrial cancer or ovarian cancer (1 products)

advanced and refractory melanoma (1 products)

High-grade serous ovarian cancer (HGSOC) (1 products)

Locally advanced non-small cell lung cancer (1 products)

resectable stage II - III non-small cell lung cancer (1 products)

resectable squamous non-small cell lung cancer (1 products)

Head and neck cancers (1 products)

Non-Small Cell Lung Cancer (1 products)

Unresectable stage IIIB-IV melanoma (1 products)

advanced urothelial carcinoma (1 products)

high grade serous ovarian carcinoma (1 products)

Pregnancy-associated melanoma (1 products)

Prostate cancer (1 products)

recurrent low-grade serous ovarian cancer (1 products)

Low-grade serous ovarian cancer (1 products)

advanced acral lentiginous melanoma (1 products)

relapsed/refractory NSCLC (1 products)

Localized Resectable Tumor, MSI/dMMR or EBV-positive Gastric Cancers (1 products)

Advanced Gastroesophageal Adenocarcinoma (1 products)

HNSCC (1 products)

Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology (1 products)

stage III non-small cell lung cancer (1 products)

Advanced/metastatic NSCLC wild-type for EGFR, ALK and ROS1 (1 products)

KRAS G12C-mutated NSCLC (1 products)

KRAS G12C wild-type NSCLC (1 products)

Advanced acral and mucosal melanoma (1 products)

resected high-risk stage III/IV cutaneous melanoma (1 products)

Advanced Solid Tumors with DNA Damage Response Gene Aberrations (1 products)

Newly diagnosed glioblastoma or anaplastic astrocytoma (1 products)

advanced non-acral cutaneous melanoma (1 products)

acral melanoma (1 products)

high-risk stage IIIB-IV melanoma (1 products)

esophageal cell carcinoma (1 products)

oesophageal squamous cell carcinoma (1 products)

high-risk ocular melanoma (1 products)

Advanced Epithelial Ovarian Cancer (1 products)

Clear Cell Carcinoma (1 products)

stage II melanoma (1 products)

localized gastric adenocarcinoma (1 products)

extensive-stage SCLC (1 products)

BRAF class II mutant/fusion positive/intragenic deletion solid tumours (1 products)

HR+/HER2- metastatic breast cancer (1 products)

AR+ triple-negative metastatic breast cancer (1 products)

MSI-H metastatic castration-resistant prostate cancer (1 products)

de novo metastatic castration-sensitive prostate cancer (1 products)

Advanced Solid Tumor Historically Known for High EphA2 Expression (1 products)

leiomyosarcoma (1 products)

Metastatic renal cell carcinoma with sarcomatoid differentiation (1 products)

Advanced renal cell carcinoma and ovarian cancer (1 products)

Gastroesophageal Junction Adenocarcinoma, Gastric Cardia Adenocarcinoma (1 products)

various cancers (1 products)

advanced squamous non-small-cell lung cancer (1 products)

early-stage non-small cell lung cancer (1 products)

Advanced or Metastatic Solid Tumors (1 products)

salivary gland tumors (1 products)

Locally advanced oral squamous cell carcinoma (LA-OSCC) (1 products)

BRAF-mutated, unresectable locally advanced stage III or oligometastatic stage IV melanoma (1 products)

advanced HER2 negative gastric, esophageal, and gastroesophageal junction adenocarcinoma (1 products)

Advanced gastric or gastroesophageal junction cancer (1 products)

HER2-positive or HER2 low solid tumors (1 products)

Locally Advanced Gastric Cancer (1 products)

advanced squamous NSCLC (1 products)

Advanced melanoma and non-small cell lung cancer (1 products)

advanced melanoma or non-small cell lung cancer (1 products)

advanced melanoma, small cell lung cancer, or non-small cell lung cancer (1 products)

Advanced Melanoma with concomitant Chronic Lymphocytic Leukemia (1 products)

high-risk muscle-invasive urothelial carcinoma (1 products)

resected stage III/IV melanoma (1 products)

EGFR-mutated, c-Met overexpressing NSCLC (1 products)

stage IIB/C melanoma (1 products)

Renal Cell Carcinoma (1 products)

metastatic castration-sensitive prostate cancer (1 products)

previously untreated, unresectable or metastatic melanoma (1 products)

Metastatic castrate-resistant prostate cancer, Advanced endometrial cancer (1 products)

recurrent ovarian cancer (1 products)

NSCLC with brain metastases (1 products)

advanced, metastatic solid tumors (1 products)

recurrent high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer (1 products)